In this regard, evaluating MYOF and VEGFR2 expression might be an efficient alternative approach to predict CCRCC outcomes since both factors are associated with poor clinical outcomes in CCRCC based on multivariate analysis. The gene discussed is MYOF; the disease is nonpapillary renal cell carcinoma.